Thus, this prompted the market growth
F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W
, -
Research shows morning-dosed peptide agonists increase fat oxidation by 1822% compared to evening dosing, sustained across an 8-hour measurement window
Operationally, one of their more controversial strategies is continuing to offer oral GLP-1 medications
This is particularly relevant given that obesity and T2DM themselves are risk factors for pancreatitis.44,45 Additionally, the prescription of GLP-1RAs is often associated with poor glycaemic control, which could be caused by occult pancreatic diseases.46,47 The treatment selection process introduces intrinsic sources of imbalance and confounding, leading to potential distortions in the results